Regeneron Pharmaceuticals (REGN) Stock Price, Quote, News & History | Benzinga

Regeneron Pharmaceuticals Inc (REGN) Stock Price, Quote, News & History

REGNNASDAQ

Trade with Public

Trade with Public

$612.14

0.660.11%

At close: Jun 12, 5:00 PM EST

$616.09

3.950.65%

After Hours: 7:52 PM EST

OverviewNews Earnings Events Options Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$613.11

Close

$612.14

Volume / Avg.

717.78K / 863.61K

Day Range

$605.01 - $616.54

52 Wk Range

503.25 - 821.11

Market Cap

$64.59B

P/E Ratio

14.93

Dividend Yield

0.61%

Exchange

NASDAQ

RSI

39

Short Interest

3.03%

Days to Cover

1.96

Recent Regeneron Pharmaceuticals Inc News

Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today

Nasdaq sinks 1.1% as AMAT, MU, ORCL and Vertiv crater on AI capex jitters, while WTI tops $106 and the 10-year yield hovers near 4.6% on stalled US-Iran talks.

Piero Cingari

Stock Market Today: Dow, S&P 500, Nasdaq Futures Drop After UAE Nuclear Plant Strike— Regeneron Pharma, NextNRG, ServiceNow In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.

Rishabh Mishra

Why Is Regeneron Stock Sinking Monday?

Regeneron melanoma combo trial missed its main goal against Keytruda despite longer progression-free survival in the high-dose arm.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

5.01B

Investing Cash Flow (TTM)

-1.71B

Financing Cash Flow (TTM)

-3.43B

Free Cash Flow (TTM)

3.79B

Capital Expenditure (TTM)

-1.22B

Net Change in Cash (TTM)

-121.20M

Analyst Trends and Forecast

3

Jan

5

2

Feb

3

Mar

5

2

Apr

6

3

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$58.13B

PE Ratio (TTM)

14.93

PE Ratio (FWD)

13.62

PEG Ratio (TTM)

1.06

PS Ratio (TTM)

4.42

PB Ratio (TTM)

2.04

Earnings Yield % (TTM)

6.70%

Earnings Yield % (FWD)

7.34%

EV / EBITDA (TTM)

10.11

Price / EBITDA (TTM)

11.47

Price / Free Cash Flow (TTM)

17.38

Book Value / Share

$299.73

Company Debt

Total Debt

$1.99B

LT Debt

$1.99B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$2.96B

Debt to Equity

0.09

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$613.11

Close

$612.14

Volume / Avg.

717.78K / 863.61K

Day Range

$605.01 - $616.54

52 Wk Range

503.25 - 821.11

Market Cap

$64.59B

P/E Ratio

14.93

Dividend Yield

0.61%

Exchange

NASDAQ

RSI

39

Short Interest

3.03%

Days to Cover

1.96

About

Sector

Health Care

Industry

Biotechnology

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet ag...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Regeneron Pharmaceuticals (REGN) stock?

A

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Regeneron Pharmaceuticals (REGN) competitors?

A

There are no as such competitors for Regeneron Pharmaceuticals.

Q

What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?

A

Regeneron Pharmaceuticals has a consensus price target of $812.17.

Q

What is the current price for Regeneron Pharmaceuticals (REGN)?

A

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $616.09 last updated June 12, 2026 at 7:52 PM EDT.

Q

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

A

There are no upcoming dividends for Regeneron Pharmaceuticals.

Q

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

A

Regeneron Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Regeneron Pharmaceuticals (REGN) going to split?

A

There is no upcoming split for Regeneron Pharmaceuticals.

Q

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

A

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.